Targeting the PH/DH Domain of Tiam1 for the Treatment and/or Prevention of Bone Metastases
Tiam1 is a highly conserved exchange factor that is over-expressed in many cancers, including prostate cancer (CRPCA). Increase in Tiam1 expression is associated with increased metastases and correlates with poor PCA patient survival prognosis. This patented technology has identified a novel compound which exhibits the ability to reduce prostate cancer...
Published: 4/3/2023
|
Inventor(s): Emmanuelle Meuillet, Sylvestor Moses, Shuxing Zhang
Keywords(s):
Category(s): Technology Classifications > Life Sciences, Technology Classifications > Life Sciences > Small Molecules
|